Reliability and Validity of the Before-School Functioning Scale in Children With ADHD

J Atten Disord. 2018 Sep;22(11):1040-1048. doi: 10.1177/1087054714564623. Epub 2015 Jan 9.

Abstract

Objective: Children with ADHD frequently manifest behavioral difficulties in the morning prior to school. We sought to assess the reliability and validity of the Before-School Functioning Questionnaire (BSFQ) as a measure of morning behaviors impaired by ADHD.

Method: We used pre-treatment data from a randomized crossover study of 6- to 12-year-old participants comparing the methylphenidate transdermal delivery system (MTS) with a placebo transdermal system (PTS) for a total of 4 weeks.

Results: The BSFQ investigator-rated scale shows very good internal homogeneity (Cronbach's α = .91), good test-retest reliability ( r = .60), good concurrent validity ( r range = .42-.86), and a strong treatment effect (effect size = -.93). The self-rated BSFQ showed lower levels of reliability and validity.

Conclusion: The investigator-rated BSFQ should be used in future trials of ADHD medications aimed at assessing efficacy in the morning before school.

Trial registration: ClinicalTrials.gov NCT00586157.

Keywords: ADHD; before school; children and adolescents; functioning; morning.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Administration, Cutaneous
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / physiopathology
  • Behavior Rating Scale
  • Child
  • Cross-Over Studies
  • Dopamine Uptake Inhibitors / administration & dosage*
  • Executive Function / drug effects
  • Female
  • Humans
  • Male
  • Methylphenidate / administration & dosage*
  • Reproducibility of Results
  • School Health Services
  • Schools
  • Surveys and Questionnaires*
  • Time Factors
  • Transdermal Patch
  • Treatment Outcome

Substances

  • Dopamine Uptake Inhibitors
  • Methylphenidate

Associated data

  • ClinicalTrials.gov/NCT00586157